Sentence examples for a borderline difference in from inspiring English sources

There was a borderline difference in average CK change between the intervention and control groups (P = 0.06).

There was a borderline difference in methylation frequency at intragenic and 3′end regions (P = 0.035 and P = 0.041, respectively) between SSAs and MSI carcinomas due to the higher number of alterations of the later (Additional file 1: Figure S1).

A borderline difference was observed in the number of total errors, which declined over time in Rac1flox but not in Rac1N mice (genotype effect, F1,13 = 3.2, P = 0.09; Fig.  2 O), while a highly significant difference was scored in the total number of visits over the 10 days of training (genotype effect, F1,17 = 54.14, P < 0.0001, Fig.  2 P).

In an earlier report on a small subsample of the present cohort, we reported a borderline difference of eGFR in participants with low and normal holoTC [ 38].

There was, however, only a borderline difference (P = 0.054) in balance improvement between the long-term withdrawers and long-term non-withdrawers.

Meta-analysis of five studies assessing IGlar in comparison with NPH, both added to OAD, revealed a borderline difference toward lower risk of overall hypoglycemia in patients treated with IGlar (RR = 0.92 [0.84, 1.001]).

After adjustment for baseline values, other group differences persisted as statistically significant but the borderline difference in systolic BP was no more statistically significant after the adjustment.

Field center representation differed between the two groups (P = 0.01), and there were borderline differences in parity, maternal age at OGTT, and sample storage time for high- versus low-FPG mothers.

Per-protocol analysis (12 patients and 14 patients in the fluvoxamine and placebo group, respectively) of the same outcomes showed no significant differences except for a borderline significant difference in the general fatigue domain of the MFI in favour of the placebo group (p = 0.04).

There were no significant differences in baseline characteristics between groups (Table 1), except for a borderline significant difference in diabetes social support (PL 4.0 vs. CHW 4.4, P = 0.053).

There was a borderline significant difference in mortality reduction with CRT-D in patients with ischaemic cardiomyopathy compared with those with non-ischaemic cardiomyopathy (unadjusted interaction P-value = 0.099, adjusted interaction P-value = 0.153), suggestive of an incremental beneficial effect of CRT-D over CRT-P in ischaemic patients, but not in patients with non-ischaemic cardiomyopathy.